8-Formylriboflavin;7-methyl-2,4-dioxo-10-D-ribitol-1-yl-2,3,4,10-tetrahydro-benzo[g]pteridine-8-carbaldehyde;α8-oxo-riboflavin (s. CA-Sach.-Reg. 1977-81);7-methyl-2,4-dioxo-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]benzo[g]pteridine-8-carbaldehyde
Disclosed are small molecules and pharmaceutical compositions comprising them that can be used in treating diseases associated with the major histocompatibility complex (MHC) molecule MR1.
公开了可用于治疗与主要组织相容性复合体(MHC)分子 MR1 有关的疾病的小分子及其药物组合物。
A Remarkable Oxidative Cascade That Replaces the Riboflavin C8 Methyl with an Amino Group during Roseoflavin Biosynthesis
作者:Isita Jhulki、Prem K. Chanani、Sameh H. Abdelwahed、Tadhg P. Begley
DOI:10.1021/jacs.6b02469
日期:2016.7.13
Roseoflavin is a naturally occurring riboflavin analogue with antibiotic properties. It is biosynthesized from riboflavin in a reaction involving replacement of the C8 methyl with a dimethylamino group. Herein we report the identification of a flavin-dependent enzyme that converts flavin mononucleotide (FMN) and glutamate to 8-amino-FMN via the intermediacy of 8-formyl-FMN. A mechanistic proposal for